FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096397 [Registered on: 23/10/2025] Trial Registered Prospectively
Last Modified On: 12/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   Measuring pesticide poison levels in patients using lab tests and to study their relation to illness severity and recovery.  
Scientific Title of Study   Quantification of Organophosphorus and Paraquat compound using gas chromatography-mass spectrometry in Acute Poisoning Patients and its Correlation with Clinical Severity Scores and Patient Outcomes : A prospective observational study in a tertiary care emergency setting.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Chaitanya CH 
Designation  Junior Resident  
Affiliation  Kasturba Medical College, Manipal 
Address  Shambhavi Habitat Apartments, Room 107, perampalli Nekkar Krishnadasa marga, vidyaratna nagar, Manipal .

Udupi
KARNATAKA
576104
India 
Phone  7795907034  
Fax    
Email  chaitanya.kmcmpl2024@learner.manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Sachin Nayak Sujir  
Designation  Associate professor  
Affiliation  Kasturba Medical College, Manipal 
Address  Department of emergency medicine, kasturba medical college, manipal

Udupi
KARNATAKA
576104
India 
Phone  9449111397  
Fax    
Email  sachin.sujir@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Chaitanya CH 
Designation  Junior Resident  
Affiliation  Kasturba Medical College, Manipal 
Address  Shambhavi Habitat Apartments, Manipal

Udupi
KARNATAKA
576104
India 
Phone  7795907034  
Fax    
Email  chaitanya.kmcmpl2024@learner.manipal.edu  
 
Source of Monetary or Material Support  
Kasturba Medical College, Manipal, Udupi district, Karnataka state, India, 576104 
 
Primary Sponsor  
Name  Kasturba Medical College 
Address  Kasturba Medical College, Manipal, 576104  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Chaitanya Chandragiri  Kasturba Medical College  Kasturba Medical Hospital, Manipal, 576104
Udupi
KARNATAKA 
7795907034

chaitanya.kmcmpl2024@learner.manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee - 2(Student Research)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: T600||Toxic effect of organophosphate and carbamate insecticides,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  85.00 Year(s)
Gender  Both 
Details  Adults above 18 years
All patients with Clinical diagnosis of acute Organophosphorus (Chlorpyrifos) or Paraquat poisoning
Presentation within 48 hours post-exposure
 
 
ExclusionCriteria 
Details  Mixed or multiple substance ingestion 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. Quantification of organophosphorus compound using GC-MS
2. Clinical severity in OP poison patients (POP score)
3. Clinical severity scoring for Paraquat poison (SIPP,serum paraquat, APACHE
And Mortality  
1. At admission
2. At admission
3. At 28 days  
 
Secondary Outcome  
Outcome  TimePoints 
1. Mortality in Organophosphorus poisoning
2. Morbidity indicator (vasopressor-free days, fewer ventilator-free days, or prolonged ICU stay) in paraquat poisoning patients

 
1. 28 days
2. At discharge
 
 
Target Sample Size   Total Sample Size="75"
Sample Size from India="75" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Title : Quantification of Organophosphorus(Chlorpyrifos) and paraquat compounds using Gas chromatography-mass spectrometry in acute poisoning patients and its correlation with clinical severity and patient outcomes.

Background: Acute pesticide poisoning is a leading cause of morbidity and mortality in India, particularly chlorpyrifos and paraquat herbicide. Clinical tools are widely used but have significant limitations as they rely on markers or clinical estimation rather than direct toxin burden. This study aims to evaluate whether GC-MS based quantification of OP and Paraquat levels correlate better with severity and clinical outcomes.

Study Summary: This is a prospective observational study to be conducted at Kasturba Medical Hospital, Manipal over a period of 2 years and 4 months. A total of 50 Chlorpyrifos OP poisoning and 25 paraquat poisoning will be enrolled, with using blood samples collected within six hours of admission with a informed consent in the patient’s own language. The collected sample will be transported to the biochemical lab under cold chain and stored in -80C. Quantified levels using GC-MS will be correlated with standard severity scores, biochemical markers and patient outcomes including 28 day mortality and morbidity will be recorded using hospital records and telephonic follow-up. 

 
Close